Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-10
2011-10-11
Jarrell, Noble (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S473000, C540S474000
Reexamination Certificate
active
08034800
ABSTRACT:
A compound of Formulae (1), (2) or (3), A1-Ph (1) or A1-Ar-A2(2) or A1-(A2)A′-A3(3) wherein A1, A2and A3are selected from Formulae 4, 5 and 6:or a salt whereof; wherein Ar is selected from the group consisting of 1,2-phenyl, 1,3-phenyl and 1,4-phenyl optionally substituted with one or more methyl groups; m and n are independently integers from 0 to 1; Ph is phenyl, optionally substituted with one or more methyl groups; Ar1is trisubstituted phenyl optionally substituted with one or more phenyl groups; and R1, R2and R3are independently selected from the group consisting of H, Me and linear chain C2-C4alkyl.
REFERENCES:
patent: 5047527 (1991-09-01), Handel et al.
patent: 5997353 (1999-12-01), Guiol
patent: 0870768 (1998-10-01), None
patent: 2000-239272 (2000-09-01), None
patent: 98/39335 (1998-09-01), None
patent: WO 98/39098 (1998-09-01), None
patent: 02/26267 (2002-04-01), None
Xu et al. Chemical Research and Toxicology, 1998, 11, pp. 247-251.
Jantzen and Robinson Modern Pharmaceutics, 1996, p. 596.
Orvedahl et al. Cell Death and Differentiation, 2009, 16, 57-69.
Liang, Xiangyang, et al., “Structure and Dynamics of Metallomacrocycles: Recognition of Zinc Xylyl-Bicyclam by an HIV Coreceptor,” J. Am. Chem. Soc. 2002, vol. 124, pp. 9105-9112.
Liang, Xiangyang, et al., “Cadmium Cyclam Complexes: Interconversion ofCisandTransConfigurations and Fixationof CO2,” Inorg. Chem 2002, vol. 41, pp. 4539-4547.
Hu, Chuanjiang, et al., “Solution-State and Solid-State Structural Characterization of Complexes of a New Macrocyclic Ligand Containing the 1,5-Diazacyclooctane Subunit,” Inorg. Chem. 2003, vol. 42, pp. 742-749.
Rosenkilde, Mette M., et al., “Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor,” The Journal of Biological Chemistry, Jan. 23, 2004, vol. 279, No. 4, pp. 3033-3041.
Achmatowicz, Michal, et al., “Direct Synthesis of 1,1′[1,4-Phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane Octahydrochloride (AMD 3100) without the Use of Protecting Groups,” J. Org. Chem. 2003, vol. 68, pp. 6435-6436.
Lebon, Bertrand, et al., “AMD3100 Conjugates as Components of Targeted Nonviral Gene Delivery Systems: Synthesis and in Vitro Transfection Efficiency of CXCR4-Expressing Cells,” Bioconjugate Chem. 2004, vol. 15, pp. 413-423.
Siegfried, Liselotte, et al., “Tren centered tris-macrocycles as polytopic ligands for CU(II) and NI(II),” The Royal Society of Chemistry 2004, pp. 2115-2124.
Princen, Katrien, et al., “Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists,” Retrovirology 2004, Mar. 8, 2004, 1:2.
Jekle Anreas, et al. “In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells,” Journal of Virology, May 2003, pp. 5846-5854.
Hatse, Sigrid, et al., “Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry,” FEBS Letters 546 (2003), pp. 300-306.
Declercq, Erik, “New developments in anti-HIV chemotherapy,” Biochimica et Biophysica Acta 1587 (2002) pp. 258-275.
Hatse, Sigrid, et al., “Mutation of Asp171 and Asp262 of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeificiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100,” Molecular Pharmacology 2001, vol. 60, pp. 164-173.
Hatse, Sigrid, et. al., “Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4,” FEBS Letters 527 (2002), pp. 255-262.
Lukacs, Nicholas W., et al., “AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity,” American Journal of Pathology, Apr. 2002 vol. 160, No. 4, pp. 1353-1360.
Blanco, Julia, et al., “The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis,” Antimicrobial Agents and Chemotherapy, Jan. 2000, pp. 51-56.
Bridger, Gary J., et. al, “A Versitile Intermediate for the Preparation of C-Functionalized Azamacrorycles and Application to the Synthesis of the Potent Anti-HIV Agent (±)JM2936,” J. Org. Chem. 1996, vol. 61, pp. 1519-1522.
Labrosse, Beatrice, et al., “Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Blcyclam AMD3100,” Journal of Virology, Aug. 1998, pp. 6381-6388.
Declercq, Erik, et al., “Potent and selective unhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event,” Proc. Natl. Acad. Sci., Jun. 1992, vol. 89, pp. 5286-5290.
Weisman, Gary R., et al., “Cross-Bridged Cyclam. Pronation and Li+ Complextion in a Diamond-Lattice Cleft,” J. Am. Chem. Soc. 1990, vol. 112, pp. 8604-8605.
Rubin, Joshua B., et al., “A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors,” PNAS, Nov. 11, 2003, vol. 100, No. 23, pp. 13513-13518.
Scotton, Chris J., et al., “Multiple Actions of the Chemokine CXCL12 on Epithelial Tumor Cells in Human Ovarian Cancer,” Cancer research, Oct. 15, 2002, vol. 62, pp. 5930-5938.
Mochizuki, Katsura, et al., “Synthesis and Structure of [6,6′-Bi(5,7-demethyl-1,4,8,11-tetraazacyclotetradecane]dinickel(II) Triflate and Its Catalytic Activity for Photochemical CO2Reduction,” Inorg. Chem. 1996, vol. 35, pp. 5132-5136.
Liang, Xiangyang, et al., “Selective Recognition of Configurational Substates of Zinc Cyclam by Carboxylates: Implications for the Design and Mechanism of Action of Anti-HIV Agents,” Chem. Eur. J. 2003, vol. 9, pp. 4709-4717.
Niu, Weijun, et al., Gallium(III) and indium(III) complexes of cross-bridged tetraamine ligands, Inorganic Chemistry Communications 2002, vol. 5, pp. 1-4.
Niu, Weijun, et al., Copper(II) and zinc(II) complexes of amide pendant-armed cross-bridged tetraamine ligands, Polyhedron 2004, vol. 23, pp. 1019-1025.
Hunter, Tina M., et al., “Configurations of metallocyclams and revelance to anti-HIV activity” Journal of Inorganic Biochemistry 2004, vol. 98, pp. 713-719.
Liang, Xiangyang, et al., “Cyclam complexes and their applications in medicine,” Chem. Soc. Rev. 2004, vol. 33, pp. 246-266.
Gaudinet-Hamann, Beatrice, et al., “A Convenient Synthesis of Bis-Tetraazamacrocycles,” Tetrehedron Letters 1999, vol. 40, pp. 287-290.
Niu, Weijun, et al., “Two novel zinc(II) complexes of the 1,8-cross-bridged cyclam ligand and their structures,” Inorganic Chemistry Communications 2 (1999), pp. 361-363.
Fabbrizzi, Luigi, et al., “pH-Controlled Florescent Emission in the Nickel(II) Complex of a Biofunctional Tetramine Macrocycle,” Inorganic Chemistry 2002, vol. 41, pp. 4612-4614.
Ciampolini, Mario, et al., “Dinickel and Dicopper Complexes with N,N-Linked Bis(cyclam) Ligands. An ideal System for the Investigation of Electrostatic Effects on the Redox Behavior of Pairs of Metal Ions,” Inorg. Chem. 1987, vol. 26, pp. 3527-3533.
Pattrick, Gary, et al., “A Crystallographic Study of a Red and a Blue Complex of Copper(II) formed with Different Geometric Isomers of a Reinforced Macrocycle,” J. Chem. Soc. Dalton Trans. 1991, pp. 1295-1299.
Paisey, Stephen J., et al., “Anti-viral cyclam macrocycles: rapid zinc uptake at physiological pH,” Chem. Commun. 2004, pp. 306-307.
Hancock, Robert D., et al., “Structurally reinforced macrocyclic ligands,” Pure & Appl. Chem. 1993, vol. 65, No. 3, pp. 473-476.
Kang, Shin-Geol, et al., “Synthesis and characterization of new adjacent-bridged tetraaza macrocyclic compounds with C-alkyl groups: crystal structure and spectral properties of a copper(II) complex,” Inorganica Chimica Ac
Archibald Stephen James
Hubin Timothy J.
Lewis Elizabeth Amie
Harness & Dickey & Pierce P.L.C.
Jarrell Noble
University of Hull
LandOfFree
Antiviral macrocycle derivatives and metal complexes,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral macrocycle derivatives and metal complexes,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral macrocycle derivatives and metal complexes,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293735